BiologicalDrug
Optivate clinical trials
- studies test it
- 10
- open now
- 0
- in phase 3
- 6
- first study started
- 2001
How studies write it
Studies that test it under each name
Studies by the year they started
10 studies that test it; most in 2001 (3)
| Year | Studies |
|---|---|
| 2001 | 3 |
| 2003 | 1 |
| 2004 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2009 | 2 |
| 2014 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 1
- Phase 3
- 6
- Phase 4
- 1
- No phase
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 10
Bio Products Laboratory (8) · City of Hope Medical Center (2)
Often tested with
Tested in the same studies.
Antihemophilic factor, human recombinant (1) · F8 protein, human (1)
Studies
Open first, then newest update. How each study uses optivate is read from its arms, and is right about nine times in ten.
Testing it · 10
- Rescue Immunotolerance Study in Induction of Immune Tolerance (ITI)-Experienced Patients (RES.I.S.T. Experienced)CompletedNot applicableCity of Hope Medical CenterNCT01051076Written as VWF/FVIII concentrates
- Post-Marketing Safety Study Following Long-Term Prophylactic OptivateTreatment in Subjects With Severe Haemophilia ATerminatedPhase 4Bio Products LaboratoryNCT01811875Written as Optivate 500IU
- Study of First TIME Immunotolerance Induction in Severe Hemophilia A Patients With Inhibitor at High Risk of Failure: Comparison With FVIII Concentrates With or Without Von Willebrand Factor - RES.I.S.T. NaiveWithdrawnNot applicableCity of Hope Medical CenterNCT01051544Written as FVIII/VWF concentrates
- An Open Study to Investigate the Safety and Efficacy of Optivate® in Haemophilia A Patients Undergoing Surgery.CompletedPhase 3Bio Products LaboratoryNCT02250482Written as Optivate® (Human Coagulation Factor VIII)
- A Study to Investigate the Safety and Efficacy of Optivate® in Children Under 6 Years of Age With Haemophilia A.CompletedPhase 3Bio Products LaboratoryNCT02246894Written as Optivate® (Human Coagulation Factor VIII)
- An Open Study to Investigate the Safety and Efficacy of Optivate® in Severe Haemophilia A Patients.CompletedPhase 3Bio Products LaboratoryNCT02246868Written as Optivate® (Human Coagulation Factor VIII)
- A Study to Compare the Pharmacokinetics and Safety of Current Factor VIII Concentrate and Optivate® in Haemophilia A.CompletedPhase 3Bio Products LaboratoryNCT02246881Written as Optivate® (Human Coagulation Factor VIII)
- A Study to Compare the Pharmacokinetics and Safety of Optivate® and Haemate P® in Patients With Von Willebrand Disease.CompletedPhase 2Bio Products LaboratoryNCT02250508Written as Optivate® (Human Coagulation Factor VIII)
- A Study With OPTIVATE® in People With Von Willebrand DiseaseTerminatedPhase 3Bio Products LaboratoryNCT00387192Written as Optivate
- Optivate in People With Von Willebrand Disease Undergoing SurgeryTerminatedPhase 3Bio Products LaboratoryNCT00404300Written as Optivate